Human Microbiome: The Unavoidable Companion “Technological Report and Market Scenario”

The global human microbiome market is nearly expected to grow by $521.23 million in 2022. This report covers its market trends analysis and its growth in the commercial market. The Human body is made up of over 100 trillion of microbes which have outnumbered human cells ten to one. The human body is an ecosystem i.e. home to trillions of microbes like bacteria, fungi, virus, etc. and the community of the microbes that resides in it is known as the human microbiome. The human microbiome is an aggregation of the microbes that reside on or within the body fluids or tissues. These communities play an important role in human physiology, immune system development, digestion, and detoxification reactions.

This report provides an in-depth diverse perspective and the importance of human microbiome in health and disease-related conditions. Alterations in human microbiome occur by exposure to various extrinsic factors like diet, xenobiotics, drugs as well as pathogens which contribute to the pathogenesis of various metabolic, neurological, immunological, and cancer-promoting diseases. It will also disclose the key aspects of the human microbiome as well as the current biotechnological tools and techniques for studying the human microbiome.

Market key players are:
Agilent technologies
Abbott
Biocartis
Others

Get Free Sample @ https://www.ingeniousreports.com/human-Microbiome-the-unavoidable-companion-technological-report-and-market-scenario

This report will also focus on global market competitive analysis as well as the Major competitors/players in this market which are actively working on the human microbiome. It will also discuss the agreements, partnerships, collaborations/ Joint Ventures, acquisitions/mergers, new products launch, other key strategies in this field.

Table of Content:
Human Microbiome: Overview
Research Scope
Research Methodology
Research Approach
Research Sources
Technical Analysis
Mode of Administration of Microbiome Products
Microbiome Product forms
Market Analysis
Market Trend Analysis
Key Microbiome Players (Company Profiling)
Key Microbiome Developments

List of Tables:
Table 1 Focus Disease Areas for Microbiome Research
Table 2 Microbiome Drug Development Approaches
Table 3 Venture Capital Investments in Microbiome Start-Ups ($ Millions
Table 4 Industry collaborations in Microbiome-based Companies ($ Millions)
Table 5 4D Pharma Pipeline
Table 6 Avidbiotics Pipeline
Table 7 Osel Pipeline
Table 8 Bioinformatic tools for metagenomic datasets analyses
Table 9 Microbiome-based Drugs in Development for Cancer
Table 10 Microbiota Associated with Type 2 Diabetes
Table 11 Microbiome-based Drugs in Development for Clostridium Difficile Infection
Table 12 Globally Patient Volumes for Microbiome-based Drugs for Type 2 Diabetes, by Company, through 2024 TABLE 22 Table 13 Globally Market for Microbiome-based Drugs for Type 2 Diabetes, by Company, through 2024
Table 14 Global Prevalence of Clostridium Difficile Infection, through 2024
Table 15 Microbiome-based Drugs in Development for Clostridium Difficile Infection
Table 16 Globally Market Shares of Microbiome-based Drugs for Clostridium Difficile Infection, by Company, 2018–2024 (%)
Table 17 Globally Patient Volumes for Microbiome-based Drugs for Clostridium Difficile Infection, by Company, through 2024 (Thousands)
Table 18 Globally Market for Microbiome-based Drugs for Clostridium Difficile Infection, by Company, through 2024 ($ Millions
Table 19 Rest of the World Market for Microbiome-based Drugs for Clostridium Difficile Infection, by Country/Region, through 2024 ($ Millions
Table 20 Microbiome-based Drugs in Development for Skin Diseases
Table 21 Microbiome-based Drugs in Development for Recurrent Bacterial Vaginosis and Urinary Tract Infection
Table 22 Microbiota Associated with Celiac Disease
Table 23 Comparison of Microbiome Sequencing Technologies

List of Figures:
Figure 1: Microbiome and human body environment
Figure 2: Human microbiome cross talk
Figure 3: Microbial Timeline
Figure 4: Human microbiome therapeutic and diagnostic applications
Figure 5: Ingredients effecting human microbiome
Figure 6: Global human microbiome market opportunity by Indication (2022)
Figure 7: Global human microbiome market (geographically)
Figure 7: Global human microbiome market (application based)
Figure 8: Global human microbiome market (product based)
Figure 9: Global human microbiome market (disease based)
Figure 10: Human Microbiome Based Drugs, Pipeline Projects
Figure 11: Human Microbiome Based Drugs, Pipeline Projects, 2016 (Number of Clinical/Preclinical Projects)
Figure 12. Gut Microbiota and Specific Commensals as Potential Preventive or Therapeutic Agents.
Figure 13. Temporal Development of the Gut Microbiota in Humans

View Full Report @ https://www.ingeniousreports.com/human-Microbiome-the-unavoidable-companion-technological-report-and-market-scenario

About us:
IngeniousReports provides one-stop solution platform for all technology, business, and market research dilemmas. We, at IngeniousReports, collaborate with leading global publishers of technology, business and market intelligence reports to industries, individuals and organizations with the endeavor of supporting them in making strategic and cost-effective business decisions.
Phone: +1 347 480 2054
Mail: sales@ingeniousreports.com

207-208, 2nd Floor, Welldone Tech Park
Sohna Road, Sector 48
Gurugram, Haryana

This release was published on openPR.